Key Points
New data plus a literature review documented new thrombosis in only 1 (2.2%) of 46 patients with acute HIT who were treated with rivaroxaban. The literature review found similarly favorable results, albeit with fewer patients, when apixaban and dabigatran were used to treat acute HIT.